The Business Times
business-time-50
SUBSCRIBERS

Vickers Venture SPAC to merge with subsidiary of Sorrento Therapeutics

google-preferred-sourceAdd BT as a preferred source
Michelle Zhu

Michelle Zhu

Published Fri, Mar 18, 2022 · 09:50 PM

    Singapore

    VICKERS Venture Partners' Nasdaq-listed special purpose acquisition company (SPAC) Vickers Vantage Corp I is merging with Scilex Holding Company, a commercial biopharmaceutical company focused on developing and commercialising non-opioid therapies for patients with acute and chronic pain.

    Scilex Holding is a subsidiary of pharma giant Sorrento Therapeutics, which is also listed on the Nasdaq.

    Vickers Venture PartnersSPACNasdaqHealthcare

    TRENDING NOW

    Jason Moo, CEO of Bank of Singapore, says the lender is hiring "pretty aggressively" in 2026.

    Size matters: OCBC’s Bank of Singapore doubles down on ultra-wealthy – and the bankers chasing them

    US President Donald Trump with President Xi Jinping after a visit to Zhongnanhai Garden in Beijing, on May 15.

    Xi Jinping has just rewritten the rules of US-China rivalry

    An article published in April notes that the share of first-year students intending to live at home has risen from 32.9% in 2016 to 35.2% in 2025. 

    Is the UK student-housing party over? Singapore players face divergent prospects in PBSA market

    An artist's impression of Pelican Paradise Group's township project that was designed to include a five-star convention hotel, an 18-hole championship golf course and a hospital, among others.

    Singapore developer in limbo after Timor-Leste scraps major township project

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More